Literature DB >> 2532615

Isochromosome not translocation in trisomy 21q21q.

M Grasso1, M L Giovannucci Uzielli, M Pierluigi, F Tavellini, L Perroni, F Dagna Bricarelli.   

Abstract

After primary trisomy, "de novo" 21q21q trisomy is the most frequent chromosomal aberration responsible for Down syndrome. This rearrangement is more commonly referred to as a Robertsonian translocation or centric fusion product than as an isochromosome, e.g., t(21q;21q) instead of i(21q); however, in practice, it has not so far proved possible to distinguish between these alternatives. The aim of this work was to establish which of the two alternatives is acceptable.

Mesh:

Year:  1989        PMID: 2532615     DOI: 10.1007/bf00210673

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  Parental age and the origin of trisomy 21. A study of 302 families.

Authors:  F Dagna Bricarelli; M Pierluigi; M Landucci; A Arslanian; D A Coviello; M A Ferro; P Strigini
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

2.  Identification of human chromosomes by DNA-binding fluorescent agents.

Authors:  T Caspersson; L Zech; C Johansson; E J Modest
Journal:  Chromosoma       Date:  1970       Impact factor: 4.316

3.  High efficiency in the attribution of parental origin of non-disjunction in trisomy 21 by both cytogenetic and molecular polymorphisms.

Authors:  F D Bricarelli; M Pierluigi; L Perroni; M Grasso; A Arslanian; N Sacchi
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

4.  Molecular evidence for true isochromosome 21q.

Authors:  J H Priest; R D Blackston; L A Pearse; S T Warren
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

5.  How do human isochromosomes arise?

Authors:  A de la Chapelle
Journal:  Cancer Genet Cytogenet       Date:  1982-02
  5 in total
  9 in total

1.  Cytogenetic and molecular analysis of a de novo tandem duplication of chromosome 21.

Authors:  J L Blouin; A Aurias; N Créau-Goldberg; F Apiou; C Alcaide-Loridan; A Bruel; M Prieur; J Kraus; J M Delabar; P M Sinet
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

2.  A molecular genetic approach to the identification of isochromosomes of chromosome 21.

Authors:  L G Shaffer; C K Jackson-Cook; J M Meyer; J A Brown; J E Spence
Journal:  Hum Genet       Date:  1991-02       Impact factor: 4.132

3.  Characterization of Robertsonian translocations by using fluorescence in situ hybridization.

Authors:  D J Wolff; S Schwartz
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

4.  Analysis of DNA polymorphisms suggests that most de novo dup(21q) chromosomes in patients with Down syndrome are isochromosomes and not translocations.

Authors:  S E Antonarakis; P A Adelsberger; M B Petersen; F Binkert; A A Schinzel
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

5.  A somatic origin of homologous Robertsonian translocations and isochromosomes.

Authors:  W P Robinson; F Bernasconi; S Basaran; M Yüksel-Apak; G Neri; F Serville; P Balicek; R Haluza; L M Farah; G Lüleci
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

6.  Leukaemia and transient leukaemia in Down syndrome.

Authors:  L Iselius; P Jacobs; N Morton
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

7.  Down syndrome due to de novo Robertsonian translocation t(14q;21q): DNA polymorphism analysis suggests that the origin of the extra 21q is maternal.

Authors:  M B Petersen; P A Adelsberger; A A Schinzel; F Binkert; G K Hinkel; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

8.  Non congenital heart disease aspects of Down's syndrome.

Authors:  S Bianca
Journal:  Images Paediatr Cardiol       Date:  2002-10

9.  Are de novo rea(21;21) chromosomes really de novo?

Authors:  Bérénice Hervé; Thibaud Quibel; Stéphane Taieb; Mireille Ruiz; Denise Molina-Gomes; François Vialard
Journal:  Clin Case Rep       Date:  2015-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.